checkAd

     441  0 Kommentare The Alliance for Regenerative Medicine Announces Inherited Blood Disorders Clinical and Patient Education Roundtable - Seite 2


    John Chapin, M.D.
    Medical Director, Clinical Research and Development - Hematology
    Shire

    Sudha Parasuraman, M.D.
    Vice President, Global Medical Affairs
    uniQure

    4:15 - 4:45pm Featured Talk: The Patient's Perspective
    John Vieke
    Patient Advocate

    4:45 - 5:00pm Closing Remarks: Next Steps
    Val Bias
    CEO
    National Hemophilia Foundation

    5:00 - 6:00pm Networking & Cocktail Reception

    This preliminary agenda is available online, with additional details to be added over the coming weeks.

    This event will take place at the Carnegie Library at Mt. Vernon Square, 801 Mt. Vernon Square NW, Washington, D.C. 20001.

    Registration is now open. The cost of attendance is $150 for industry attendees; $75 for non-profit and government attendees. The event is complimentary for patients, patient advocates, clinician attendees and members of the media. For more information and to register, please visit http://alliancerm.org/event/clinical-patient-education-inherited-blood-disorder-roundtable.

    For questions regarding this event, please contact ARM's Patient Advocacy & Events Manager Chelsey Hathaway, chathaway@alliancerm.org. For media interested in attending this event, please contact ARM's Senior Director of Communications Lyndsey Scull, lscull@alliancerm.org.

    About The Alliance for Regenerative Medicine

    The Alliance for Regenerative Medicine (ARM) is an international multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine worldwide. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, D.C. to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today, ARM has more than 250 members and is the leading global advocacy organization in this field. To learn more about ARM or to become a member, visit http://www.alliancerm.org.

    The Alliance for Regenerative Medicine
    Lyndsey Scull
    202 213 7086
    lscull@alliancerm.org

    Seite 2 von 2


    Diskutieren Sie über die enthaltenen Werte



    Verfasst von Marketwired
    The Alliance for Regenerative Medicine Announces Inherited Blood Disorders Clinical and Patient Education Roundtable - Seite 2 WASHINGTON, DC--(Marketwired - Nov 17, 2016) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced it will hold its …